Delivery Order SPE2DB20D3103-SPE2DB22FP7Z8
Award Date 9/7/22
Potential Completion Date 9/8/22
Potential Value $50K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $9,367.78 for the supply of XIFAXAN 550 MG TABLET 60S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $28,577.16 delivery order contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of January 31, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,399.60 for the supply of XIFAXAN 550 MG tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. The award is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical division. This IDC serves as the primary...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $15,735.93 delivery order is for the supply of XIFAXAN 550 mg tablets, a specialty medication, to support military and government healthcare programs. The contract has a completion date of September 8, 2022 and is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen holds a...
- The federal contract awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order with a ceiling value of $25,845.94 for the procurement of Xifaxan 550 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, with a completion date of May 17, 2022. This contract is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a Delivery Order valued at $6,879.15 for the supply of the pharmaceutical product XIFAXAN 550 MG TABLET 60S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through June 26, 2023. The contract is a Firm Fixed Price arrangement and was not designated as a set-aside. Amerisourcebergen is a major pharmaceutical distributor that holds several...
- This federal contract award, valued at $10,925.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of the pharmaceutical product XIFAXAN 550 mg Tablet 60s. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC serves as a primary...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $26,532.89, is for the delivery of XIFAXAN 550 mg tablets. This award is not associated with any set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that plays a critical role in supplying medical...
- This federal contract award, valued at $1,316.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with a performance period ending on March 11, 2024. This is a firm-fixed-price delivery order contract, and there is no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This contract award, with a ceiling value of $5,456.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with a performance period ending on May 18, 2023. This is a Firm Fixed Price Delivery Order contract, without any set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a significant...